194 related articles for article (PubMed ID: 2427580)
1. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
Koo GC; Manyak CL
J Immunol; 1986 Sep; 137(6):1751-6. PubMed ID: 2427580
[TBL] [Abstract][Full Text] [Related]
2. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
Kalland T; Belfrage H; Bhiladvala P; Hedlund G
J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
[TBL] [Abstract][Full Text] [Related]
4. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
Koo GC; Dumont FJ; Tutt M; Hackett J; Kumar V
J Immunol; 1986 Dec; 137(12):3742-7. PubMed ID: 3782794
[TBL] [Abstract][Full Text] [Related]
5. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
Suzuki R; Suzuki S; Ebina N; Kumagai K
J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells generated from bone marrow culture.
Koo GC; Peppard JR; Mark WH
J Immunol; 1984 May; 132(5):2300-4. PubMed ID: 6201540
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 3 is a major negative regulator of the generation of natural killer cells from bone marrow precursors.
Kalland T
J Immunol; 1986 Oct; 137(7):2268-71. PubMed ID: 2876040
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
Hinuma S; Naruo K; Shiho O; Tsukamoto K
Immunology; 1986 Oct; 59(2):251-9. PubMed ID: 3490435
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
11. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
12. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
Hurwitz JL; McAndrew EC; Doherty PC
J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109
[TBL] [Abstract][Full Text] [Related]
13. Population dynamics of natural killer cells in the spleen and bone marrow of normal and leukemic mice during in vivo exposure to interleukin-2.
Christopher FL; Dussault I; Miller SC
Immunobiology; 1991 Dec; 184(1):37-52. PubMed ID: 1800310
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
[TBL] [Abstract][Full Text] [Related]
15. Generation of lymphokine-activated killer cell activity from human thymocytes.
Ramsdell FJ; Golub SH
J Immunol; 1987 Sep; 139(5):1446-53. PubMed ID: 2442246
[TBL] [Abstract][Full Text] [Related]
16. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
17. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
18. Generation of natural killer cells from bone marrow precursors in vitro.
Kalland T
Immunology; 1986 Apr; 57(4):493-8. PubMed ID: 3485566
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
20. Precursor phenotype of lymphokine-activated killer cells in the mouse.
Salup RR; Mathieson BJ; Wiltrout RH
J Immunol; 1987 Jun; 138(11):3635-9. PubMed ID: 3108370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]